HHS To Delay Drug Pricing Rule To July 2019
A subagency of the U.S. Department of Health and Human Services is delaying a rule establishing ceiling prices on outpatient drugs under the 340B Drug Pricing Program and fines for violating manufacturers...To view the full article, register now.
Already a subscriber? Click here to view full article